Tarang Sharma
Technical officer, Novel medicines platform & HTA, WHO
Tarang Sharma, PhD, MSc, MPH, has over two decades of experience in health policy development and implementation. She currently works for the World Health Organization Regional Office for Europe as a Technical Officer for the Novel Medicines Platform and Health Technology Assessment, working to support strategic cooperation between all stakeholders for improved access of medicines to patients and supporting HTA capacity building for the Region.
Prior to this, she worked for the Agenda, Policy & Strategy unit in the Immunization, Vaccines and Biologicals department at the WHO HQ in Geneva, supporting evidence to policy recommendations for the new COVID-19 vaccines and has previously worked for evidence to policy impact and health research mechanisms both at WHO HQ and WHO Europe as a senior consultant and a technical officer.
She has worked for three different national governments, in USA (AMNH in New York City as a Research Associate), in UK (for NICE as a Senior Analyst) and in Denmark (for the Danish Medicines Council: Medicinrådet, as a Specialist Consultant Advisor). She has also worked for non-governmental agencies/ non-state actors with Cochrane Denmark in Copenhagen as well as was part of the Cochrane Central Executive Team at their headquarters in London, UK and previously for Akanksha and Kutumb Foundations in India. She has worked as a health economist for the University of Sheffield in UK and for Novo Nordisk A/S in Denmark and on pre-clinical research as a Research Scientist for Ranbaxy laboratories Ltd (now bought by Sun Pharma) in India.